42 Baroness Neville-Rolfe debates involving the Department of Health and Social Care

Children and Young People: Obesity

Baroness Neville-Rolfe Excerpts
Tuesday 17th April 2018

(7 years, 10 months ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Baroness Neville-Rolfe Portrait Baroness Neville-Rolfe (Con)
- Hansard - -

My Lords, this debate takes place at dinner time, which is an ideal time if I may say so. I congratulate the noble Baroness, Lady Walmsley, on gathering us all together to discuss this important area.

Obesity is a subject that I have grappled with since the early 2000s when, as a Tesco employee, I sat on the foresight obesity panel under the auspices of the business department and its Government Office for Science. This was in an era when, on the positive side, serious research and objective facts generally ruled in public policy. On the negative side, we came up with a report the most striking output of which was a vast spaghetti-style map—which I have with me if any noble Lords would like to see it afterwards. It mapped the causes and avenues of obesity, but it was so complex that it defeated the system and, perhaps as a result, gathered minimal attention.

I made a contribution later with colleagues at Tesco by introducing workplace initiatives such as free fruit and Race for Life—the noble Lord, Lord Addington, is right that mass sport is definitely a positive—and by pioneering traffic-light labels on food packaging. Indeed, broadly the same system was eventually adopted on a national basis by the then Secretary of State, my noble friend Lord Lansley. These labels are used for calorie counting, for avoiding sugar if you are diabetic, for keeping down fat if you have coronary risk and for encouraging manufacturers to reduce salt. I would be interested to hear whether the Minister knows of any evidence of the impact of this traffic-light measure, especially on the vital younger age groups that we are talking about today.

I do not want to go over the ground that others have already covered, but want to make a scientific point and a moral point. On the science of diet, there appears to be more disagreement than one might expect. Too many calories should obviously be avoided, but the relative merits, or demerits, of fat and carbohydrates seem still to be a matter of surprising disagreement—I was interested in what my noble friend Lord McColl said about low fat and sugar. My hunch as a past fan of Elizabeth David is that there is a lot to be said for the Mediterranean diet; that is, lots of fruit and vegetables, of vegetable oil and of fish. However, it would be helpful to be certain about it. These disagreements among experts are not helpful for progress.

My scientific point concerns another area, sleep, which, as it happens, did not appear specifically on our huge obesity map in 2007. There have been some serious advances in the science of sleep in recent years, but the vital point is that there is strong emerging evidence that poor, disturbed or insufficient sleep is a significant contributor to obesity, even if the precise mechanism is imperfectly understood. There are various ways to improve sleep, such as by avoiding white light and wearing a Fitbit-type device—which allows you to monitor your sleep pattern on your phone and go to bed at a more consistent time, apparently a key to success. More publicity about the advantages of better sleep patterns for weight reduction could help many who struggle with weight problems.

We have moved from a world where many people were short of food to one where, outside the most unfortunate countries such as North Korea or some in Africa, people have access to more food than is good for them. This has its own challenges. My moral point is that, whatever the scientific facts, obesity will not be tackled successfully unless those at risk can demonstrate self-control. It is no use blaming others, food manufacturers or the fears that prevent children walking to school, as I did every day from the age of five—it was quite a long way, for our own failings. The main fault, dear Brutus, lies not in others but in ourselves. As far as young people are concerned, we need to convince them that self-control is needed to avoid obesity—and for many other desirable outcomes. This is not a convenient conclusion—it is so much easier to blame others for our own shortcomings—but it is no less valid for that and is very important in tackling the obesity epidemic among our children and young people today.

NHS: Cancer Treatments

Baroness Neville-Rolfe Excerpts
Thursday 25th January 2018

(8 years ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Baroness Neville-Rolfe Portrait Baroness Neville-Rolfe (Con)
- Hansard - -

My Lords, I would like to congratulate the noble Baroness, Lady Jowell, on arranging this debate, and express my extreme admiration for her brave and moving speech. It is an honour to be able to add praise for all she has done and for the battle that she and her family have fought. As a result of her efforts, I believe that she will help many in the future who are less fortunate than her.

My younger sister died of cancer last year. She was a successful novelist with a great capacity to make friends and an extraordinary knowledge of culture and languages. But she had a pain and she did what so many women do, which was to struggle on and delay seeking medical help, with fatal consequences. In spite of the brilliance of the doctors in Dartmouth, New Hampshire, she died within two years of her first pain. So I am speaking today not only to commend the noble Baroness, Lady Jowell, but to encourage everyone to seek medical advice in such circumstances, and to endorse the Government’s scheme for referring possible cancer cases to hospital within two weeks.

Since I have a business background, I want to make two other points. The first is to commend the pharmaceutical sector for its many breakthroughs. Of course university research and development is critical, and we have an extraordinary share of Nobel Prizes in this country, but we also have great firms: AstraZeneca, GSK and smaller innovative sisters which apply capital and data, do trials and create a business model that can help millions of patients and shareholders—for example, our pension funds. These businesses have a real role in the task of finding innovative solutions for hard-to-tackle cancers, including brain cancer, which we are discussing today.

The second is to highlight the role of business-focused corporate responsibility. When I was at Tesco, we created a partnership with Cancer Research UK called Race for Life. Every year we organised 200 or 300 races in parks across Britain, with a lead event in Battersea Park. I ran it 11 years on the trot. They were amazing experiences, with women young and old, from our checkout to David Cameron’s office. There was always a splendid turnout of MPs and leaders like Helen Alexander, who sadly died of cancer herself last year. And there was always a bevy of Baronesses to add a touch of class and shed a few pounds, and some of you are here today. That was fun, but the important thing is that we raised a vast amount of money for Cancer Research UK—over £400 million in that period—and we increased the salience of cancer research through our TV ads and promotions. And on the back of every runner was scribbled a message about a friend with cancer, or a friend who had died of cancer—a very emotional experience. In that era cancer recovery rates accelerated. We were in the right place at the right time. I wish the noble Baroness’s campaign similar success.